Clinical Trial: Multimodal Biomarkers and Precision TMS for Postpartum Depression

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757815) titled 'Multimodal Biomarkers and Precision TMS for Postpartum Depression' on July 28.

Brief Summary: The purpose of this study is to identify multimodal biological markers associated with postpartum depression (PPD) and to evaluate the effectiveness of precision brain stimulation treatment. PPD is a common mental health condition after childbirth that can affect maternal well-being and early child development. Current identification of PPD relies largely on clinical assessments and screening questionnaires, which may not fully capture underlying biological changes. This study uses brain activity, cardiac signals, blood-based biomarkers, in...